PMC:7799378 / 19484-19680 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"775","span":{"begin":27,"end":32},"obj":"Gene"},{"id":"791","span":{"begin":103,"end":111},"obj":"Disease"}],"attributes":[{"id":"A775","pred":"tao:has_database_id","subj":"775","obj":"Gene:3552"},{"id":"A791","pred":"tao:has_database_id","subj":"791","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"bitory peptides as well as IL-1β, are potential therapeutic interventions for reducing the severity of COVID-19 [102,103].\nThe inflammasome is part of the innate immune system that regulates effec"}